Table 2.
Resistance of A. baumannii strains to different antibiotics comparing 2016–2017 and 2021–2022.
| Antimicrobial Drug | 2016–2017 N = 130 n (%) |
2021–2022 N = 103 n (%) |
p |
|---|---|---|---|
| Ampicillin/sulbactam | 104 (80.0) | 96 (93.2) | 0.004 |
| Piperacillin/tazobactam | 127 (97.7) | 103 (100.0) | 0.257 |
| Ceftazidime | 129 (99.2) | 102 (99.0) | 1.0 |
| Cefepime | 124 (95.4) | 100 (97.1) | 0.735 |
| Imipenem | 127 (97.7) | 102 (99.0) | 0.632 |
| Meropenem | 127 (97.7) | 102 (99.0) | 0.632 |
| Ciprofloxacin | 130 (100.0) | 103 (100.0) | – |
| Gentamicin | 111 (85.4) | 89 (86.4) | 0.824 |
| Tobramycin | 124 (95.4) | 93 (90.3) | 0.127 |
| Amikacin | 105 (80.8) | 87 (84.5) | 0.462 |
| Tigecycline | 80 (61.5) | 99 (96.1) | <0.001 |
| Tetracycline | 81 (62.3) | 103 (100.0) | <0.001 |
| Doxycycline | 42 (32.3) | 99 (96.1) | <0.001 |
| Trimethoprim/sulfamethoxazole | 124 (95.4) | 69 (67.0) | <0.001 |